EN DE
Watch HASS Corp for free: we tell you when fair value or trend changes.
Data-driven stock valuation

HASS Corp (450330) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of HASS Corp stock KRW 3,552, price KRW 3,755, that is 5.4% below the price, quality 35 out of 100. Rating: fairly valued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare KR

HC HASS Corp logo Some data Nov 3, 2026

HASS Corp

450330 · KQ
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Low debt
Fair value 3,552 KRW · Fairly valued
Expensive Growth (revenue 3y +3.6 %/yr in KRW)
Loss over the last twelve months · -1.0% net margin (TTM) · fiscal year 2025 9.3%
1.6% dividend yield · Watch coverage
Mixed vs. peers (5/12)
Some data
Revenue last quarter 11% below a year ago.
Quality 35/100
Negative free cash flow
Narrow moat 21/100 · thin data
Watch HASS Corp for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

16,819 KRW 3,755 KRW Fair Value 3,552 KRW Jul 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

28‑month range 3,755 KRW – 16,819 KRW · fair‑value band 2,486 KRW – 4,412 KRW · the 3,755 KRW price screens above the 3,552 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow HASS in your weekly email

Every Wednesday you see whether HASS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Hass Corp. manufactures and sells dental medical devices.

Show moreShow less

Its CAD/CAM systems include Amber Mill, a machinable dental glass-ceramic blocks made of lithium disilicate; Amber Mill Direct, a CAD/CAM-based millable lithium disilicate block; Amber Mill H, a CAD/CAM block using nano-crystalline ceramics particle; Amber Mill Q, an implant abutment solution; and Amber Mill Meso, a lithium disilicate-based block for implant prosthese.

The company's heat-pressing systems comprise Amber Press, a lithium disilicate-based press ingots; Amber Press Master, a lithium disilicate-based high fusion press ingots; and Amber LiSi-POZ and Amber LiSi-POM for lithium disilicate-based press on zirconia.

In addition, it offers Amber Vest, an ultra-fine phosphate bound investment for pressable dental ceramics; COCO Lux, a mobile dental photography solution; Selection Tip, a shade matching solution; and Amber Glow, a polish for zirconia, lithium disilicate, porcenlain, and composite.

The company was founded in 2008 and is headquartered in Gangneung-si, South Korea.

Stock analysis

HASS Corp (450330) currently trades at 3,755 KRW, while our model-based Fair Value estimate is 3,552 KRW, so the stock looks roughly fairly valued today (gap 5.7%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 3,781 KRW per share, and 4 of the 15 models we run sit above the 3,755 KRW price.

Bear case: the Dividend Discount group reads lowest at 1,060 KRW, and 11 of the 15 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 2,486 KRW (bear) to 4,412 KRW (bull), the price of 3,755 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

HASS Corp reported revenue of 16.6B KRW in FY2025 versus 12.6B KRW in FY2021, a compound +7.1%/yr. Reported net income was 1.5B KRW in FY2025, compounding −0.2%/yr from FY2021.

Key figures

Market cap 30.7B KRW (≈ $22.7M) Micro · P/S ratio 1.96 · EPS (TTM) −20.19 KRW · Dividend yield 1.6% · Net margin −1.0% · Return on equity −0.4% · Return on assets (EBIT) 7.1% (5-year average) · Operating margin −14.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 21 out of 100 (low confidence).

What moves the price

The share trades about 52% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −5%, 450330 screens cheaper than that median.

Fair Value models

Bear 2,486 KRW Fair Value 3,552 KRW Bull 4,412 KRW
Price 3,755 KRW · Downside -5.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income 4,410 KRW 4,315 KRW 4,412 KRW 73
EPV 1,646 KRW 1,796 KRW 1,928 KRW 71
ROIC Compounder 1,646 KRW 1,796 KRW 1,928 KRW 69
All 15 models by family
Earnings-Based
Graham-Dodd 1,358 KRW 3,194 KRW 4,111 KRW 63
PEG = 1.0 549.22 KRW 784.59 KRW 1,020 KRW 55
EPV 1,646 KRW 1,796 KRW 1,928 KRW 71
Dividend Discount
Gordon GGM 657.18 KRW 1,141 KRW 1,744 KRW 64
DDM Multi-Stage 657.18 KRW 978.27 KRW 1,336 KRW 64
Multiples
P/E Multiple 3,294 KRW 4,392 KRW 5,490 KRW 63
P/S Multiple 2,545 KRW 3,394 KRW 4,242 KRW 58
P/B Multiple 19,631 KRW 26,175 KRW 32,718 KRW 55
EV/EBIT 916.09 KRW 1,411 KRW 1,906 KRW 65
EV/EBITDA 2,983 KRW 4,167 KRW 5,351 KRW 67
EV/Revenue 491.09 KRW 945.20 KRW 1,399 KRW 51
Asset-Based
NCAV (Graham) 1,602 KRW 2,427 KRW 3,033 KRW 54
Economic Profit
Residual Income 4,410 KRW 4,315 KRW 4,412 KRW 73
ROIC Compounder 1,646 KRW 1,796 KRW 1,928 KRW 69
Growth Earnings
Growth-Adj P/E 2,486 KRW 3,552 KRW 4,617 KRW 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 35/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 29
How much profit the company makes from its sales and capital
Quality Growth 43
Are margins and returns getting better?
Cashflow 25
Do the profits arrive as real cash?
Financial strength 72
Debt, balance sheet and risk of trouble
Investment 12
Does it invest with discipline instead of growing at any price?
Low Volatility 58
How calm the share price moves, does not count
Price momentum 17
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 52
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 33/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+0.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−1.0%
Dividend (yield on the price)1.6%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 5%

Watch 450330, get fair value alerts →

Compare HASS Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 35 · Bottom 25%
Fair Value upside −5.4% · Above median
Profitability
Return on assets 2.8% · Below median
Net margin (12 months) −1.0% · Bottom 25%
Operating margin (12 months) −14.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −10.6% · Bottom 25%
Dividend yield (12 months) 1.6% · Above median
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 0.66× · Cheapest 25%
P/S (12 months) 1.91× · Cheaper than median
EV/EBITDA 22.7× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)26 · sector 25
FUTURE (revenue growth)0 · sector 40
PAST (return on equity)0 · sector 30
HEALTH (low debt)99 · sector 96
DIVIDEND (yield)32 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.38 $131.27 +45% vs 450330
EssilorLuxottica Société anonyme EL €193.80 €196.22 +1% vs 450330
Intuitive Surgical, Inc ISRG $452.80 $353.90 −22% vs 450330
Medline Inc MDLN $39.64 $28.59 −28% vs 450330
Alcon Inc ALC CHF 61.30 CHF 34.06 −44% vs 450330
Becton, Dickinson and Company BDX $211.88 $97.80 −54% vs 450330
Straumann Holding STMN CHF 104.50 CHF 45.50 −56% vs 450330
West Pharmaceutical Services, Inc WST $399.81 $139.22 −65% vs 450330
Sartorius Stedim Biotech S.A DIM €225.80 €54.82 −76% vs 450330
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs 450330

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

HASS Corp: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "HASS Corp Fair Value". https://www.fairvalue-calculator.com/stock/450330

Frequently asked questions

Is HASS Corp (450330) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 3,552 KRW versus a price of 3,755 KRW, about 5% lower (fairly valued).
What is the fair value of 450330?
Our model-based fair value for HASS Corp is 3,552 KRW (as of Nov 3, 2026), built from audited fundamentals. The current price: 3,755 KRW.
What is the quality score of 450330?
HASS Corp has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HASS Corp (450330)?
Our model-based price target is the fair value of 3,552 KRW (as of Nov 3, 2026) from 15 valuation models. Cautious scenario 2,486 KRW, optimistic scenario 4,412 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the HASS Corp stock forecast for 2026?
Our models put fair value at 3,552 KRW, about 5% lower versus a price of 3,755 KRW (fairly valued). Cautious scenario 2,486 KRW, optimistic scenario 4,412 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of HASS Corp (450330)?
HASS Corp reported trailing-twelve-month revenue of about 16.1B KRW (latest available figure, as of Nov 3, 2026).
Does HASS Corp pay a dividend?
HASS Corp currently shows a dividend yield of 1.60% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of HASS Corp (450330) and when is the ex-dividend date?
HASS Corp pays a dividend of 60.00 KRW per share a year, a dividend yield of 1.6%. The last ex-dividend date was Mar 18, 2026. The payout ratio is 30.1% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of HASS Corp (450330)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HASS Corp it is 3,552 KRW per share (as of Nov 3, 2026), against a price of 3,755 KRW. It is the blended result of 15 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is HASS Corp stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 450330 trades above its calculated fair value: price 3,755 KRW, fair value 3,552 KRW, a gap of about −5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 450330?
No. The price is what the market pays today (3,755 KRW); the fair value is what the company's own numbers justify (3,552 KRW). For HASS Corp the two are 203.48 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is HASS Corp worth?
The market values HASS Corp at about 30.7B KRW (market capitalisation, as of Nov 3, 2026). Per share that is 3,755 KRW; our models calculate a fair value of 3,552 KRW per share.
What do the bullish and bearish scenarios say about 450330?
Our models span a range for HASS Corp: cautious scenario 2,486 KRW, base 3,552 KRW, optimistic 4,412 KRW per share (as of Nov 3, 2026, price 3,755 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HASS Corp (450330)?
Balance-sheet figures for HASS Corp (as of Nov 3, 2026): return on equity −0.4%, debt of 0.03 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is 450330 from its 52-week high?
HASS Corp trades at 3,755 KRW, about 52% below its 52-week high of 7,800 KRW and at the low of 3,755 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 3,552 KRW is for.
Which stocks are comparable to HASS Corp?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HASS Corp stock attractive at the current price?
The data as of Nov 3, 2026: price 3,755 KRW, calculated fair value 3,552 KRW (−5%), Quality Score 35/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 450330 calculated?
We run HASS Corp through 15 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 3,552 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. HASS Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HASS Corp (450330)?
The closing price on Nov 6, 2026 was 3,755 KRW. Our model-based fair value is 3,552 KRW, about 5% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HASS Corp right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of HASS Corp

How large is the market capitalisation of HASS Corp (450330)?
The market capitalisation of HASS Corp is 30.7B KRW (≈ $22.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HASS Corp (450330)?
The price-to-sales ratio of HASS Corp is 1.96 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of HASS Corp (450330)?
Earnings per share at HASS Corp are −20.19 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of HASS Corp (450330)?
The dividend yield of HASS Corp is 1.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of HASS Corp (450330)?
The net margin of HASS Corp is −1.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HASS Corp (450330)?
The return on equity (ROE) of HASS Corp is −0.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HASS Corp (450330)?
On an EBIT basis the return on assets of HASS Corp is 7.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HASS Corp (450330)?
The operating margin of HASS Corp is −14.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HASS Corp (450330)?
Revenue at HASS Corp is growing −10.6% versus a year earlier (3y avg +3.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HASS Corp (450330)?
Earnings per share at HASS Corp are growing −11.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does HASS Corp (450330) generate?
The free cash flow of HASS Corp is −409M KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does HASS Corp (450330) carry?
The net debt of HASS Corp is 4.4B KRW (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch HASS Corp in the live analysis

One click puts HASS Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.